Sarah B. Nahhal MD , Johnny Zakhour MD , Abdel Hadi Shmoury MD , Tedy Sawma MD , Sara F. Haddad MD , Tamara Abdallah MSc , Nada Kara Zahreddine CIC , Joseph Tannous MHRM , Nisrine Haddad Pharm D , Nesrine Rizk MD , Souha S. Kanj MD
{"title":"Blood Stream Infections in COVID-19 Patients From a Tertiary Care Center in Lebanon: Causative Pathogens and Rates of Multi-Drug Resistant Organisms","authors":"Sarah B. Nahhal MD , Johnny Zakhour MD , Abdel Hadi Shmoury MD , Tedy Sawma MD , Sara F. Haddad MD , Tamara Abdallah MSc , Nada Kara Zahreddine CIC , Joseph Tannous MHRM , Nisrine Haddad Pharm D , Nesrine Rizk MD , Souha S. Kanj MD","doi":"10.1016/j.mayocpiqo.2023.10.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To report the microbiological profile of the pathogens implicated in blood stream infections (BSI) in hospitalized coronavirus disease 2019 (COVID-19) patients and to examine the risk factors associated with multidrug-resistant organisms (MDROs) causing BSI.</p></div><div><h3>Patients and Methods</h3><p>Between March 2020 and September 2021, 1647 patients were hospitalized with COVID-19 at the American University of Beirut. From 85 patients, 299 positive blood cultures were reported to the Infection Control and Prevention Program. The BSI was defined as 1 positive blood culture for bacterial or fungal pathogens. The following organisms were considered MDROs: methicillin-resistant <em>Staphylococcus aureus</em>, vancomycin-resistant <em>Enterococcus</em> spp, carbapenem-resistant <em>Enterobacterales</em> spp., carbapenem-resistant <em>Pseudomonas aeruginosa</em>, MDR <em>Acinetobacter baumannii</em> only susceptible to colistin or tigecycline, and <em>Candida auris.</em></p></div><div><h3>Results</h3><p>We identified 99 true positive BSI events. Gram-negative bacteria accounted for 38.4 %, followed by Gram-positive bacteria (37.4%), and fungi (24.2%). The most isolated species were <em>Candida</em> spp. (23%), 3 of which were <em>C. auris</em>, followed by <em>Enterobacterales</em> spp. (13%), <em>Enterococcus</em> spp. (12%), <em>S. aureus</em> (9%), <em>P. aeruginosa</em> (9%), and <em>A. baumannii</em> (3%). The MDROs represented 26% of the events. The overall mortality rate was 78%. The time to acquisition of BSI in patients with MDROs was significantly longer compared with that of non-MDROs (20.2 days vs 11.2 days). And there was a significantly shorter time from acquisition of BSI to mortality between MDROs and non-MDROs (1.5 vs 8.3 days).</p></div><div><h3>Conclusion</h3><p>Rigorous infection prevention and control measures and antimicrobial stewardship are important to prevent antimicrobial resistance progression, especially in low-resource settings.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000681/pdfft?md5=b0a82eabdc062d57635e0b37f75841c8&pid=1-s2.0-S2542454823000681-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mayo Clinic proceedings. Innovations, quality & outcomes","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2542454823000681","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To report the microbiological profile of the pathogens implicated in blood stream infections (BSI) in hospitalized coronavirus disease 2019 (COVID-19) patients and to examine the risk factors associated with multidrug-resistant organisms (MDROs) causing BSI.
Patients and Methods
Between March 2020 and September 2021, 1647 patients were hospitalized with COVID-19 at the American University of Beirut. From 85 patients, 299 positive blood cultures were reported to the Infection Control and Prevention Program. The BSI was defined as 1 positive blood culture for bacterial or fungal pathogens. The following organisms were considered MDROs: methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp, carbapenem-resistant Enterobacterales spp., carbapenem-resistant Pseudomonas aeruginosa, MDR Acinetobacter baumannii only susceptible to colistin or tigecycline, and Candida auris.
Results
We identified 99 true positive BSI events. Gram-negative bacteria accounted for 38.4 %, followed by Gram-positive bacteria (37.4%), and fungi (24.2%). The most isolated species were Candida spp. (23%), 3 of which were C. auris, followed by Enterobacterales spp. (13%), Enterococcus spp. (12%), S. aureus (9%), P. aeruginosa (9%), and A. baumannii (3%). The MDROs represented 26% of the events. The overall mortality rate was 78%. The time to acquisition of BSI in patients with MDROs was significantly longer compared with that of non-MDROs (20.2 days vs 11.2 days). And there was a significantly shorter time from acquisition of BSI to mortality between MDROs and non-MDROs (1.5 vs 8.3 days).
Conclusion
Rigorous infection prevention and control measures and antimicrobial stewardship are important to prevent antimicrobial resistance progression, especially in low-resource settings.